Ultra Nasdaq Biotechnology Proshares (BIB) 67.98

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra Nasdaq Biotechnology Proshares (BIB) 67.98 $BIB

After Yesterday's Rally of 1.01% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 26, 5:37PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $61.23 to a high of $65.61. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $63.25 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 67.98 (+1.56)

BUYINS.NET: NEPT, SBH, AIMC, CVLT, MHH, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 23, 8:02AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Neptun SA (NASDAQ:NEPT), Sally Beauty Holdings Inc (NYSE:SBH), Altra Holdings Inc (NASDAQ:AIMC), CommVault Systems Inc (NASDAQ:CVLT), Mastech Holdings Inc (NYSE:MHH), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 67.98 (+1.56), SBH: 24.83 (+0.96), MHH: 7.90 (unch), CVLT: 39.49 (-0.01), AIMC: 26.66 (-0.23), NEPT: 1.17 (unch)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 1.04%
Comtex SmarTrend(R) - Mon Oct 19, 4:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $60.36 to a high of $65.30. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $64.21 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 67.98 (+1.56)

ProShares Ultra Nasdaq Biotechnology ETF Down 6.7% Since SmarTrend Downtrend Call (BIB)
Comtex SmarTrend(R) - Mon Oct 19, 10:15AM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on September 24th, 2015 at $68.46. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 6.71% as of today's recent price of $63.86.
BIB: 67.98 (+1.56)

ProShares Ultra Nasdaq Biotechnology ETF Down 13.2% Since SmarTrend Downtrend Call (BIB)
Comtex SmarTrend(R) - Fri Oct 09, 10:07AM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on September 24th, 2015 at $68.46. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 13.15% as of today's recent price of $59.45.
BIB: 67.98 (+1.56)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound After Falling 7.24% Yesterday
Comtex SmarTrend(R) - Tue Oct 06, 5:07PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $54.30 to a high of $61.24. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $56.25 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 67.98 (+1.56)

Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 31.37 (-0.80), BIB: 67.98 (+1.56), UBIO: 54.49 (+2.13), LABU: 20.35 (+0.41), LABD: 36.67 (-0.82), ZBIO: 23.60 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Rebound After Yesterday's Selloff of 8.82%
Comtex SmarTrend(R) - Mon Sep 21, 4:35PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $73.40 to a high of $83.54. Yesterday, the shares fell 8.8%, which took the trading range below the 3-day low of $79.97 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 67.98 (+1.56)

BUYINS.NET: TQQQ, FNGN, BIB, PLOW, RLOC, AOR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 03, 6:37AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Trust UltraPro QQQ ETF (NASDAQ:TQQQ), Financial Engines Inc (NASDAQ:FNGN), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Douglas Dynamics Inc (NYSELOW), REACHLOCAL INCORPORATION (NASDAQ:RLOC), iShares S&P Growth Allocation ETF (NYSE:AOR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FNGN: 32.98 (-0.55), BIB: 67.98 (+1.56), PLOW: 21.88 (-0.30), RLOC: 0.74 (+0.04), TQQQ: 113.78 (+0.60), AOR: 39.30 (+0.02)

Downtrend Call Working As ProShares Ultra Nasdaq Biotechnology ETF Stock Falls 17.1% (BIB)
Comtex SmarTrend(R) - Tue Sep 01, 5:28PM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on May 20th, 2015 at $86.93. In approximately 3 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 17.08% as of today's recent price of $72.08.
BIB: 67.98 (+1.56)

After Yesterday's Decline of 1.03%, ProShares Ultra Nasdaq Biotechnology ETF Offers Investors Better Value
Comtex SmarTrend(R) - Fri Aug 07, 4:29PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $85.88 to a high of $90.99. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $90.00 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 67.98 (+1.56)

BUYINS.NET: BRXX, SPB, BIB, SDRL, QAI, BORN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Aug 04, 7:27AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EGShares Brazil Infrastructure ETF (NYSE:BRXX), Superior Plus Corp (NYSE:SPB), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Seadrill Ltd (NYSE:SDRL), IQ Hedge Multi-Strategy Tracker ETF (NYSE:QAI), China New Borun Corp (NYSE:BORN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BORN: 1.14 (-0.15), BRXX: 6.20 (+0.05), BIB: 67.98 (+1.56), QAI: 28.80 (-0.01), SDRL: 6.04 (-0.20), SPB: 90.74 (-0.55)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 4.54% Gain
Comtex SmarTrend(R) - Tue Jul 14, 5:10PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $95.13 to a high of $99.84. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $95.56 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 67.98 (+1.56)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.36% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 06, 5:38PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $88.72 to a high of $93.56. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $93.18 on volume of 469,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 67.98 (+1.56)

10-Minute Guide to 10 Most Popular Leveraged ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jun 23, 9:00AM CDT
Here a handy guide to the 10 most popular leveraged ETFs for short-term investors seeking to ride out the bull run.
UYG: 72.94 (+0.08), QLD: 77.90 (+0.20), UPRO: 63.92 (-0.03), UCO: 17.85 (-1.18), BIB: 67.98 (+1.56), SSO: 63.77 (-0.01), UWTI: 6.90 (-0.69), NUGT: 23.21 (-2.89), FAS: 30.37 (+0.02), TQQQ: 113.78 (+0.60)

Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT

BBP: 30.78 (+0.43), PBE: 50.50 (+1.05), BBC: 29.07 (+0.05), SBIO: 30.80 (+0.29), BIS: 31.37 (-0.80), HQL: 25.37 (+0.44), FBT: 109.73 (+1.71), BIB: 67.98 (+1.56), XBI: 68.49 (+0.34), BBH: 123.58 (+1.61), IBB: 328.66 (+3.77), LABU: 20.35 (+0.41), LABD: 36.67 (-0.82)

ProShares Ultra Nasdaq Biotechnology ETF Falls 2.35% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 09, 5:14PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $85.40 to a high of $88.48. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $85.73 on volume of 729,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 67.98 (+1.56)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Independents Finally Center Stage on Election Night

Updated Category News Views 36

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 46

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 96

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
111, Inc. Strategizes with Advisors Amid Proposal Talks

Updated Category News Views 112

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Continue Reading
American Water's $10K Grant Boosts Student Financial Skills

Updated Category News Views 0

Financial Literacy: Building Skills for the Future When it comes to prepping kids for the real world, it's not just about packing their backpacks with textbooks and pencils; it's about arming them with the know-how to make smart financial moves. American Water Charitable Foundation's recent $10,000 grant to Junior Achievement of the Heartland is a shining example of the...

Continue Reading
Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Updated Category News Views 111

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

Continue Reading
Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Updated Category News Views 64

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Continue Reading
Mesirow Expands Retirement Reach with flexPATH Deal

Updated Category News Views 126

Retirement Industry Shake-Up Here's the scoop: Mesirow's swinging big in the retirement scene with its latest acquisition of flexPATH's plan-level 3(38) business. In the world of outsourced fiduciarity—for thems ain't in the know—that's like bolting a turbocharger to an already darn good engine. Mesirow might just be strapping itself in for a wild ride in this 2026...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 135

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
Sinopec's Catalyst Conference: Driving Global Innovation

Updated Category News Views 90

The Role of Catalysts in Modern Industry Swing by any bustling industrial hub, and you're likely to catch talk about catalysts—unsung heroes that make the machinery of modern industry run smoother, faster, and cleaner. Over in Tianjin, China, Sinopec just wrapped up its Second International Catalyst Customer Conference, which is less of a tongue-twister than it sounds....

Continue Reading

Top 5 Most Recently Viewed Articles

Rezolve Ai Achieves Major Growth with Russell Index Inclusion

Updated Category News Views 322

Rezolve Ai Celebrates Inclusion in Prestigious Russell Indices Rezolve Ai (NASDAQ: RZLV) has reached a significant milestone in its journey by being added to the Russell 2000 and Russell 3000 indices. This achievement comes as a result of an immensely successful year, with the company's annual recurring revenue (ARR) soaring to $70 million, showcasing its rapid growth...

Continue Reading
VitalHub Demonstrates Growth with Strong 2024 Financials

Updated Category News Views 369

VitalHub Reports Impressive Financial Growth VitalHub Corp, a prominent software provider in health and human services, recently reported robust financial results for 2024. The company disclosed significant advancements in their Annual Recurring Revenue (ARR), which surged 59% year over year, reaching $71.1 million. Additionally, the total revenue increased by a...

Continue Reading
Artius II Acquisition Inc. Launches $200 Million IPO on Nasdaq

Updated Category News Views 229

Artius II Acquisition Inc. Launches Its Initial Public Offering In an exciting development for investors and the market, Artius II Acquisition Inc. has unveiled its initial public offering (IPO) priced at an impressive $200 million. This marks a significant moment for the company as it takes steps to expand its reach in the investment landscape. Understanding the IPO...

Continue Reading
Surge in Foreign Capital Sparks Japanese Stock Market Growth

Updated Category News Views 85

Foreign Investment Surge in Japanese Stocks Recent trends indicate a remarkable increase in foreign investments in Japanese stocks, particularly noted in the week ending October 5. Following comments from Prime Minister Shigeru Ishiba regarding monetary policy, the yen experienced a depreciation, enhancing the appeal of Japanese exporters to foreign buyers. Significant...

Continue Reading
Jason Maynard Takes the Helm as CEO of Qualtrics

Updated Category News Views 194

Qualtrics Welcomes Jason Maynard as New CEO Qualtrics, a pioneer in experience management, has recently appointed Jason Maynard as its Chief Executive Officer. Maynard, who will also take a seat on the Qualtrics Board of Directors, officially steps into this influential role today. A Leader with Proven Experience With an impressive background of 30 years in the technology...

Continue Reading